youtube_live
Приходи за Q3 2026 • публикувано • Приходите на акция са над прогнозите +5,68% • Приходите са над прогнозите +4,92%
Преглед на резултатитеchevron_right
RVTY:NYSE
Revvity Inc
157,47 щ.д.
arrow_upward
+4,40%(+6,64) 1 д.
6.11, 13:56:56 ч. Гринуич-5 · USD
search
Всички символи
| Символ | Цена | Промяна | % промяна |
|---|
insights_autoГенерира се водещата статистика за RVTY…
Отваряне
150,83 щ.д.
Висока
158,96 щ.д.
Ниска
149,38 щ.д.
Пазарна кап.
16,83 млрд.
Ср. обем
1,89 млн.
Обем
908,32 хил.
Най-висока цена за 52 седм.
171,74 щ.д.
Най-ниска цена за 52 седм.
81,22 щ.д.
Бета-версия
1,08
Акции в обращение
111,59 млн.
Брой служители
11 хил.
Отваряне
150,83 щ.д.
Висока
158,96 щ.д.
Ниска
149,38 щ.д.
Пазарна кап.
16,83 млрд.
Ср. обем
1,89 млн.
Обем
908,32 хил.
Най-висока цена за 52 седм.
171,74 щ.д.
Най-ниска цена за 52 седм.
81,22 щ.д.
Бета-версия
1,08
Акции в обращение
111,59 млн.
Брой служители
11 хил.
Новинарски материали
От източници в мрежата и новинарски партньори
Zacks
·
преди 2 часа
All You Need to Know About Revvity (RVTY) Rating Upgrade to Buy
GuruFocus
·
преди 1 ден
RVTY Maintained by Barclays -- Price Target Raised to $175
Investing.com
·
преди 2 дни
Stifel raises Revvity stock price target to $177 on AI demand
TradingView
·
преди 2 дни
Revvity Q3 Earnings Call Highlights
Профил
Revvity, Inc. is a multinational company headquartered in Waltham, Massachusetts, USA, in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.
In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY. Wikipedia
Всичко за Revvity Inc
Главен изпълнителен директорПрахлад Сингх
Служители11 хил.
Дата на основаване1947
Централен офисWaltham, Масачузетс, Съединени щати
БраншHealth Care
Индустрия-
Уебсайтrevvity.com